Therapeutic Oligonucleotides 2008
DOI: 10.1039/9781847558275-00226
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for the Delivery of Oligonucleotides in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2011
2011

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…A major practical limitation of these anionic liposomes, however, is their limited ability to encapsulate ONs due to a lack of electrostatic interaction (6,7). Cationic liposomes can effectively sequester ONs, but they also display unspecific binding to serum components or endothelia (8)(9)(10). We recently demonstrated that both efficient loading of ON and high biocompatibility can be achieved with the use of amphoteric liposomes (11).…”
Section: Introductionmentioning
confidence: 99%
“…A major practical limitation of these anionic liposomes, however, is their limited ability to encapsulate ONs due to a lack of electrostatic interaction (6,7). Cationic liposomes can effectively sequester ONs, but they also display unspecific binding to serum components or endothelia (8)(9)(10). We recently demonstrated that both efficient loading of ON and high biocompatibility can be achieved with the use of amphoteric liposomes (11).…”
Section: Introductionmentioning
confidence: 99%